Coronavirus vaccine frontrunner Pfizer delivers key trial data – here’s where the other vaccines stand

[CNBC] Because of the pandemic, U.S. officials and drugmakers have been accelerating the development of vaccine candidates by investing in multiple stages of research. The U.S. has doled out billions to help develop a vaccine and secure doses if and when one is approved. Pfizer and Moderna are slightly ahead […]

Read More

Stock Market Update For The Week Ahead: ‘Cautious Attitude’

[Benzinga] The Last Week In A Nutshell What Happened: “U.S. stocks are closing in on record highs. But behind the scenes, uneasy investors are keeping their options open,” said Lindsey Bell, chief investment officer for Ally Financial Inc-owned (NYSE: ALLY) Ally Invest. “They’ve bought gold at a historical pace, boosting the metal’s price to nine-year […]

Read More

Why Moderna Stock Dropped Today

[The Motley Fool, Getty Images] Skeptics are questioning the biotech’s recent coronavirus vaccine-related announcements. What happened Shares of Moderna (NASDAQ:MRNA) fell nearly 9% on Thursday, continuing a downward trend that began soon after the biotechnology company’s recent stock sale. So what Moderna’s stock soared on Monday after it released positive data from its phase 1 […]

Read More